JIANGSU HAINEKON BIOTECHNOLOGY CO LTD

Overview

JIANGSU HAINEKON BIOTECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE (ATP) TRIS SOLUTION; CAP 4 M7G(UNA)(5')PPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTION; CAP 5 M7G(5')VPPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTION; CAP GAG; CYTIDINE TRIPHOSPHATE.

API / Drug Master Files

JIANGSU HAINEKON BIOTECHNOLOGY CO LTD holds 16 active (16 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• T7 RNA POLYMERASEActive2025-09-27
• URIDINE TRIPHOSPHATE (UTP)Active2024-08-16
• CAP 4 M7G(UNA)(5')PPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTIONActive2024-06-28
• CAP 5 M7G(5')VPPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTIONActive2024-06-28
• ADENOSINE TRIPHOSPHATE (ATP) TRIS SOLUTIONActive2024-03-21
• CYTIDINE TRIPHOSPHATE (CTP) TRIS SOLUTIONActive2024-03-20
• GUANOSINE TRIPHOSPHATE (GTP) TRIS SOLUTIONActive2024-03-19
• N1-METHYL-PSEUDOURIDINE 5'-TRIPHOSPHATE(N1-ME-PUTP) TRIS SOLUTIONActive2024-03-18
• INN NAME: 5-OME-UTPActive2023-03-28
• CAP GAGActive2023-01-05
• M7(3'OMEG)(5')PPP(5')(2'OMEA)PGActive2022-12-25
• CYTIDINE TRIPHOSPHATEActive2022-12-23
• ADENOSINE TRIPHOSPHATEActive2022-12-22
• GUANOSINE TRIPHOSPHATE (GTP)Active2022-12-22
• N1-ME-PSEUDO-UTPActive2022-06-23

Showing 15 of 16 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU HAINEKON BIOTECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.